Expression of Programmed Death-Ligand 1 in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed and Nonsun-Exposed Skin

BACKGROUND: A recent clinical trial has shown the efficacy of an anti-programmed death-1 (PD-1) antibody against advanced squamous cell carcinoma (SCC). The expression of PD-ligand 1 (PD-L1) in tumor cells correlates with a favorable response to anti-PD-1 therapy in various malignancies. In recent s...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Hiroyuki, Sugita, Kazunari, Yamamoto, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810068/
https://www.ncbi.nlm.nih.gov/pubmed/33487707
http://dx.doi.org/10.4103/ijd.IJD_187_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810068/
https://www.ncbi.nlm.nih.gov/pubmed/33487707
http://dx.doi.org/10.4103/ijd.IJD_187_19

Ejemplares similares